SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Protein Design Labs (PDLI): Stock strong
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
407 58 0 PDLI
Emcee:  Stanley Cowen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
207Int J Cancer 2001 Aug 15;93(4):556-65 Humanization and characterization of thescaram(o)uche-5/14/2002
206Protein Design Labs Begins Phase I Trial of Remitogen(TM) in Cancer Patients Witnigel bates-5/14/2002
205>>FREMONT, Calif., May 9 /PRNewswire-FirstCall/ -- Protein Design Labs, Intuck-5/9/2002
204FREMONT, Calif., May 1 /PRNewswire-FirstCall/ -- Protein Design Labs, Inc. (PDL;nigel bates-5/1/2002
203More from SSB: <snip NPSP sections> * PDLI: Incremental Phase I/II resumopgcw-4/17/2002
202From SSB: We expect Protein Design Labs (PDL) to break-even in fiscal Q1 2002, mopgcw-4/17/2002
201I sure wish I had bought more yesterday. I seriously considered it but didn'Charles Tutt-3/21/2002
200Today's laugh: >>Protein Design Labs (Nasdaq: PDLI - news) jumped 14tuck-3/21/2002
199well in afterhours it opened at -+ 11 and rose to 14+ so think this aint a disadalroi-3/21/2002
198I don't think anybody will be buying this rock to open tomorrow. MSDW, if stsun-tzu-3/21/2002
197It was a good call. Good question if they will follow that up with some actiomopgcw-3/20/2002
196<i>Others, though, have said investors should wait for Zenapax study resulnigel bates-3/20/2002
195Anyone, I just began following this stock a few days ago and I'm looking folazarre-3/15/2002
194Protein Design Up 6% Ahead Of Zenapax Phase II Trial Data DOW JONES NEWSWIRES mopgcw-3/13/2002
193Protein Design Labs Begins Phase II Trial of Nuvion(TM) In Steroid-Refractory Grnigel bates-3/11/2002
192Hi Nig, Doesn't the press release state that a Zamyl patient is 15% more liIan@SI-12/7/2001
191Protein Design Labs Announces Positive Phase III Clinical Results With Zamyl(TM)nigel bates-12/7/2001
190Additional Cancer Targets Delivered by Exelixis to Protein Design Labs Message 1nigel bates-11/27/2001
189Stocks split for many reasons. One such reason would be so bigger money can accSilver_Bullet-10/11/2001
188Many biotechs don't have ANY earnings. I guess you think _they_ should _nevCharles Tutt-10/11/2001
187Here is an example of stock that should not have split only because of market prSkeet Shipman-10/11/2001
186Wow, no one follows this guy? What up with that? It's too bad because thisSilver_Bullet-8/30/2001
185SOUTH SAN FRANCISCO, Calif. and FREMONT, Calif., July 11 /PRNewswire/ -- Just onnigel bates-7/11/2001
184KIRKLAND, Wash. & PALO ALTO, Calif.--(BUSINESS WIRE)--July 11, 2001--Rosettanigel bates-7/11/2001
183FREMONT, Calif. and SOUTH SAN FRANCISCO, Calif., May 22 /PRNewswire/ -- Protein nigel bates-5/22/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News